Spero Therapeutics
SPRO
SPRO
35 hedge funds and large institutions have $110M invested in Spero Therapeutics in 2018 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 11 increasing their positions, 7 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
5% less funds holding
Funds holding: 37 → 35 (-2)
29% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 7
Holders
35
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$3.63M | |
| 2 | +$934K | |
| 3 | +$779K | |
| 4 |
State Street
Boston,
Massachusetts
|
+$451K |
| 5 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
+$350K |
Top Sellers
| 1 | -$6.9M | |
| 2 | -$365K | |
| 3 | -$170K | |
| 4 |
DIM
DC Investments Management
Mclean,
Virginia
|
-$118K |
| 5 |
TCIM
TIAA CREF Investment Management
New York
|
-$103K |